These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32365074)

  • 1. Biokinetic model of radioiodine I-131 in nine thyroid cancer patients subjected to in-vivo gamma camera scanning: A simplified five-compartmental model.
    Huang CC; Lin YH; Kittipayak S; Hwua YS; Wang SY; Pan LK
    PLoS One; 2020; 15(5):e0232480. PubMed ID: 32365074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective half life of iodine for five thyroidectomy patients using an in vivo gamma camera approach.
    Chen CY; Chang PJ; Changlai SP; Pan LK
    J Radiat Res; 2007 Nov; 48(6):485-93. PubMed ID: 17971626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biodistribution of radioiodine on posttherapy iodine-131 scans in thyroid cancer patients with chronic renal failure.
    Aktaş A; Kavak K; Kocabaş B; Aras M; Tütüncü NB; Gençoğlu A
    Nucl Med Commun; 2008 Nov; 29(11):943-8. PubMed ID: 18836371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
    Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of diagnostic dilemmas in 131I whole body scanning.
    Leitha T; Staudenherz A
    Nuklearmedizin; 2003; 42(2):55-62. PubMed ID: 12695787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I effective half-life and dosimetry in thyroid cancer patients.
    Remy H; Borget I; Leboulleux S; Guilabert N; Lavielle F; Garsi J; Bournaud C; Gupta S; Schlumberger M; Ricard M
    J Nucl Med; 2008 Sep; 49(9):1445-50. PubMed ID: 18703593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Our solution for fusion of simultaneusly acquired whole body scintigrams and optical images, as usesful tool in clinical practice in patients with differentiated thyroid carcinomas after radioiodine therapy. A useful tool in clinical practice.
    Matovic M; Jankovic M; Barjaktarovic M; Jeremic M
    Hell J Nucl Med; 2017; 20 Suppl():159. PubMed ID: 29324929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and dosimetry of (131)I in thyroidectomy patients using semiquantitative gamma-camera imaging.
    Changlai SP; Chang PJ; Chen CY
    Cancer Biother Radiopharm; 2008 Dec; 23(6):759-66. PubMed ID: 19111047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.
    Luster M; Sherman SI; Skarulis MC; Reynolds JR; Lassmann M; Hänscheid H; Reiners C
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1371-7. PubMed ID: 12856155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative evaluation of multiple biokinetic models using an assembled water phantom: A feasibility study.
    Yeh DM; Chen CY; Tang JF; Pan LK
    PLoS One; 2017; 12(12):e0189244. PubMed ID: 29267305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.
    Melo DR; Brill AB; Zanzonico P; Vicini P; Moroz B; Kwon D; Lamart S; Brenner A; Bouville A; Simon SL
    Radiat Res; 2015 Dec; 184(6):595-610. PubMed ID: 26579944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Findings for Differentiated Thyroid Carcinoma by γ-Camera-Based and Uptake-Probe-Based Methods in Comparison with Diagnostic Radioiodine Scanning.
    Menon B; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2019 Sep; 47(3):238-242. PubMed ID: 30413599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between estimated glomerular filtration rate and biological half-life of 131I. Retrospective analysis in patients with differentiated thyroid carcinoma.
    Vogel K; Opfermann T; Wiegand S; Biermann J; Busch M; Winkens T; Freesmeyer M
    Nuklearmedizin; 2013; 52(5):164-9. PubMed ID: 23821288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.
    Huić D; Medvedec M; Dodig D; Popović S; Ivancević D; Pavlinovic Z; Zuvic M
    Nucl Med Commun; 1996 Oct; 17(10):839-42. PubMed ID: 8951903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I Biokinetics and cytogenetic dose estimates in ablation treatment of thyroid carcinoma.
    Nascimento AC; Lipsztein JL; Corbo R; Rebelo AM
    Health Phys; 2010 Oct; 99(4):457-63. PubMed ID: 20838086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
    Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
    Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.